{"id":8502,"date":"2026-03-11T10:15:42","date_gmt":"2026-03-11T10:15:42","guid":{"rendered":"https:\/\/blogs.uwe.ac.uk\/research-external-engagement\/?p=8502"},"modified":"2026-03-20T12:44:51","modified_gmt":"2026-03-20T12:44:51","slug":"the-fragile-lifeline-reinventing-how-we-make-and-move-blood","status":"publish","type":"post","link":"https:\/\/blogs.uwe.ac.uk\/research-external-engagement\/the-fragile-lifeline-reinventing-how-we-make-and-move-blood\/","title":{"rendered":"The fragile lifeline: Reinventing how we make and move blood"},"content":{"rendered":"\n

Most of us picture blood donation as simple: book an appointment, donate, have a biscuit, and your blood becomes someone else\u2019s lifeline. But as Episode 13 of the Let\u2019s Talk Health and Care podcast<\/a><\/strong> reveals, the reality is far more complex and far more fragile.<\/p>\n\n\n\n

In The Fragile Lifeline: Rethinking How We Make and Move Blood<\/em>, hosts Marc Griffiths<\/a> and Peter Brindle are joined by Professor Wendy Phillips<\/a> and Dr Helen Sanderson<\/a> to explore a question that sits at the heart of healthcare resilience:<\/p>\n\n\n\n

What if the future of blood supply isn\u2019t about bigger donations but smarter manufacturing?<\/strong><\/p>\n\n\n\n

Why the blood supply chain is more vulnerable than we realise<\/strong><\/h3>\n\n\n\n

Wendy and Helen unpack the hidden complexity behind every blood transfusion. Blood isn\u2019t a single product: it\u2019s separated into components, tested, tracked, and cross-matched with rigorous checkpoints at every stage. And because blood products are highly temperature-sensitive, even a small break in the \u201ccold chain\u201d can mean it becomes unusable.<\/p>\n\n\n\n

The episode also highlights how disruption can ripple quickly across the system. From seasonal drops in donor numbers to extreme heat impacting storage conditions, the supply chain is under constant pressure. Wendy points to the seriousness of these risks by referencing an incident where a cyberattack on a third-party supplier had significant knock-on impacts, contributing to shortages and raising concerns about how close the system can come to critical levels.<\/p>\n\n\n\n

The message is clear: blood supply is a lifeline but it\u2019s a lifeline with weak points.<\/p>\n\n\n\n

Making blood closer to where it\u2019s needed<\/strong><\/h3>\n\n\n\n

The conversation then shifts to the future: redistributed manufacturing<\/em> – producing critical healthcare products closer to the point of need, at the scale required, when they\u2019re required.<\/p>\n\n\n\n

Dr Sanderson draws on work with defence partners to explain the logistical reality: blood products often need frequent resupply, have short shelf lives, and rely on refrigerated storage which can lead to waste even as teams must stay prepared for worst-case scenarios.<\/p>\n\n\n\n

The innovation isn\u2019t only about the blood itself, either. The episode surfaces a key (often overlooked) point: packaging is part of resilience. If essential medical packaging is sourced from a single nation or relies on fragile materials like glass, that\u2019s another pressure point in an already delicate system.<\/p>\n\n\n\n

What innovations are on the horizon?<\/strong><\/h3>\n\n\n\n

This episode offers a genuinely fascinating glimpse of what \u201cnext\u201d could look like and what might arrive sooner than people expect.<\/p>\n\n\n\n

Among the approaches discussed:<\/p>\n\n\n\n